Sex disparities and the risk of urolithiasis: a large cross-sectional study

References

• Ferraro PM, Taylor EN, Gambaro G, et al. Dietary and lifestyle risk factors associated with incident kidney stones in men and women. J Urol. 2017;198(4):1627–863.
   Web of Science ®Google Scholar
• Chien TM, Lu YM, Li CC, et al. A retrospective study on sex difference in patients with urolithiasis: who is more vulnerable to chronic kidney disease? Biol Sex Differ. 2021;12(1):40.
   PubMed Web of Science ®Google Scholar
• van de Pol JAA, van den Brandt PA, Schouten LJ. Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: The Netherlands cohort study. Br J Cancer. 2019;120(3):368–374.
   PubMed Web of Science ®Google Scholar
• Tundo G, Khaleel S, Pais VM Jr. Gender equivalence in the prevalence of nephrolithiasis among adults younger than 50 years in the United States. J Urol. 2018;200(6):1273–1277.
   PubMed Web of Science ®Google Scholar
• Gillams K, Juliebø-Jones P, Juliebø S, et al. Gender differences in kidney stone disease (KSD): findings from a systematic review. Curr Urol Rep. 2021;22(10):50.
   PubMed Web of Science ®Google Scholar
• Kim S, Chang Y, Sung E, et al. Non-alcoholic fatty liver disease and the development of nephrolithiasis: a cohort study. PLOS One. 2017;12(10):e0184506.
   PubMed Web of Science ®Google Scholar
• Kim S, Chang Y, Yun KE, et al. Metabolically healthy and unhealthy obesity phenotypes and risk of renal stone: a cohort study. Int J Obes. 2019;43(4):852–861.
   Web of Science ®Google Scholar
• Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23(Suppl 16):S165–S9.
   PubMed Web of Science ®Google Scholar
• Wang X, Luo Y, Wang Y, et al. Comparison of associations of outcomes after stroke with estimated GFR using Chinese modifications of the MDRD study and CKD-EPI creatinine equations: results from the China national stroke registry. Am J Kidney Dis. 2014;63(1):59–67.
   PubMed Web of Science ®Google Scholar
• Xu JZ, Lu JL, Hu L, et al. Sex disparities in the association of serum uric acid with kidney stone: a cross-sectional study in China. Front Med. 2022;9:774351.
   Web of Science ®Google Scholar
• Brisbane W, Bailey MR, Sorensen MD. An overview of kidney stone imaging techniques. Nat Rev Urol. 2016;13(11):654–662.
   PubMed Web of Science ®Google Scholar
• Kim S, Chang Y, Yun KE, et al. Development of nephrolithiasis in asymptomatic hyperuricemia: a cohort study. Am J Kidney Dis. 2017;70(2):173–181.
   PubMed Web of Science ®Google Scholar
• Kim S, Chang Y, Jung HS, et al. Glycemic status, insulin resistance, and the risk of nephrolithiasis: a cohort study. Am J Kidney Dis. 2020;76(5):658–668.e1.
   PubMed Web of Science ®Google Scholar
• Vicedo-Cabrera AM, Goldfarb DS, Kopp RE, et al. Sex differences in the temperature dependence of kidney stone presentations: a population-based aggregated case-crossover study. Urolithiasis. 2020;48(1):37–46.
   PubMed Web of Science ®Google Scholar
• Goldfarb DS, Avery AR, Beara-Lasic L, et al. A twin study of genetic influences on nephrolithiasis in women and men. Kidney Int Rep. 2019;4(4):535–540.
   PubMed Web of Science ®Google Scholar
• Lin H, Zhu X, Long J, et al. HIPK2 polymorphisms rs2058265, rs6464214, and rs7456421 were associated with kidney stone disease in Chinese males not females. Gene. 2018;653:51–56.
   PubMed Web of Science ®Google Scholar
• Huang H, Li M, Fan H, et al. Temporal trend of urolithiasis incidence in China: an age-period-cohort analysis. IJGM. 2021;ume 14:2533–2539.
   Web of Science ®Google Scholar
• Zeng Q, He Y. Age-specific prevalence of kidney stones in Chinese Urban Inhabitants. Urolithiasis. 2013;41(1):91–93.
   PubMed Web of Science ®Google Scholar
• Mitchell T, De Miguel C, Gohar EY. Sex differences in redox homeostasis in renal disease. Redox Biol. 2020;31:101489.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang Y, Zhang J, et al. Recent advances on the mechanisms of kidney stone formation (review). Int J Mol Med. 2021;48(2):149.
   PubMed Web of Science ®Google Scholar
• Lin CY, Liu JM, Wu CT, et al. Decreased risk of renal calculi in patients receiving androgen deprivation therapy for prostate cancer. IJERPH. 2020;17(5):1762.
   Web of Science ®Google Scholar
• Changtong C, Peerapen P, Khamchun S, et al. In vitro evidence of the promoting effect of testosterone in kidney stone disease: a proteomics approach and functional validation. J Proteomics. 2016;144:11–22.
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhao Z, Chou F, et al. Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals. Cell Death Dis. 2019;10(4):275.
   PubMed Web of Science ®Google Scholar
• Prochaska M, Taylor EN, Curhan G. Menopause and risk of kidney stones. J Urol. 2018;200(4):823–828.
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhao Z, Chou FJ, et al. The protective roles of estrogen receptor β in renal calcium oxalate crystal formation via reducing the liver oxalate biosynthesis and renal oxidative stress-mediated cell injury. Oxid Med Cell Longev. 2019;2019:5305014.
   PubMed Web of Science ®Google Scholar
• Peerapen P, Thongboonkerd V. Protective cellular mechanism of estrogen against kidney stone formation: a proteomics approach and functional validation. Proteomics. 2019;19(19):e1900095.
   PubMed Web of Science ®Google Scholar
• Nackeeran S, Katz J, Ramasamy R, et al. Association between sex hormones and kidney stones: analysis of the national health and nutrition examination survey. World J Urol. 2021;39(4):1269–1275.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Fan Y, Wang M, et al. Kidney stone disease and cardiovascular events: a study on bidirectional causality based on mendelian randomization. Transl Androl Urol. 2021;10(12):4344–4352.
   PubMed Web of Science ®Google Scholar
• Lubinus Badillo FG, Cala OLO, Vera Campos SN, et al. Relationship between urolithiasis and fatty liver disease: findings in computed tomography, tomography. Tomography. 2020;6(1):1–4.
   PubMed Web of Science ®Google Scholar
• Ding Q, Ouyang J, Fan B, et al. Association between dyslipidemia and nephrolithiasis risk in a Chinese Population. Urol Int. 2019;103(2):156–165.
   PubMed Web of Science ®Google Scholar
• Khan SR, Pearle MS, Robertson WG, et al. Kidney stones. Nat Rev Dis Primers. 2016;2:16008.
   PubMed Web of Science ®Google Scholar
• Ibis F, Yu TW, Penha FM, et al. Nucleation kinetics of calcium oxalate monohydrate as a function of pH, magnesium, and osteopontin concentration quantified with droplet microfluidics. Biomicrofluidics. 2021;15(6):064103.
   PubMed Web of Science ®Google Scholar
• Parks JH, Coe FL, Evan AP, et al. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009;24(1):130–136.
   PubMed Web of Science ®Google Scholar
• Türk C, Petřík A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol. 2016;69(3):468–474.
   PubMed Web of Science ®Google Scholar
• Manissorn J, Fong-Ngern K, Peerapen P, et al. Systematic evaluation for effects of urine pH on calcium oxalate crystallization, crystal-cell adhesion and internalization into renal tubular cells. Sci Rep. 2017;7(1):1798.
   PubMed Web of Science ®Google Scholar